JESSICA STOLZ: Open Payments
NPI 1003093790 · MARIETTA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$637 in 32 payments from 12 companies in 2025. Trend: 2023 $872 · 2024 $908 · 2025 $637
Food & beverage: $637
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $178 |
| Novo Nordisk Inc | 10 | $143 |
| GlaxoSmithKline, LLC. | 4 | $65 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $52 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $36 |
| Averitas Pharma Inc. | 1 | $36 |
| ABBVIE INC. | 2 | $34 |
| Alkermes, Inc. | 1 | $25 |
| Phathom Pharmaceuticals, Inc. | 1 | $20 |
| Lilly USA, LLC | 1 | $16 |
Products named: FARXIGA, Ozempic, Wegovy, TRELEGY ELLIPTA, CAPLYTA, JARDIANCE, QUTENZA, VRAYLAR.
Industry payments across OH — which companies pay providers there.
